BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 28869200)

  • 1. Irreversible electroporation and thermal ablation of tumors in the liver, lung, kidney and bone: What are the differences?
    Vroomen LGPH; Petre EN; Cornelis FH; Solomon SB; Srimathveeravalli G
    Diagn Interv Imaging; 2017 Sep; 98(9):609-617. PubMed ID: 28869200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irreversible electroporation: ready for prime time?
    Lu DS; Kee ST; Lee EW
    Tech Vasc Interv Radiol; 2013 Dec; 16(4):277-86. PubMed ID: 24238383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microwave tumors ablation: principles, clinical applications and review of preliminary experiences.
    Carrafiello G; Laganà D; Mangini M; Fontana F; Dionigi G; Boni L; Rovera F; Cuffari S; Fugazzola C
    Int J Surg; 2008; 6 Suppl 1():S65-9. PubMed ID: 19186116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor ablation: common modalities and general practices.
    Knavel EM; Brace CL
    Tech Vasc Interv Radiol; 2013 Dec; 16(4):192-200. PubMed ID: 24238374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New tumor ablation techniques for cancer treatment (microwave, electroporation).
    de Baere T; Deschamps F
    Diagn Interv Imaging; 2014; 95(7-8):677-82. PubMed ID: 24818966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Irreversible Electroporation Ablation as Adjunctive Treatment for Margin Enhancement: Safety and Efficacy.
    Simmerman E; Chung J; Lawson A; Kruse E
    J Surg Res; 2020 Feb; 246():260-268. PubMed ID: 31610354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New techniques of tumor ablation (microwaves, electroporation)].
    de Baere T
    J Radiol; 2011 Sep; 92(9):789-95. PubMed ID: 21944237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ablative therapies: Advantages and disadvantages of radiofrequency, cryotherapy, microwave and electroporation methods, or how to choose the right method for an individual patient?
    Seror O
    Diagn Interv Imaging; 2015 Jun; 96(6):617-24. PubMed ID: 25981214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible electroporation for colorectal cancer liver metastasis: a review.
    Koethe Y; Wilson N; Narayanan G
    Int J Hyperthermia; 2022; 39(1):682-687. PubMed ID: 35469520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ablation of the locally advanced pancreatic cancer: An introduction and brief summary of techniques.
    Petrou A; Moris D; Paul Tabet P; David Wensley Richards B; Kourounis G
    J BUON; 2016; 21(3):650-8. PubMed ID: 27569086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niche Applications of Irreversible Electroporation.
    Bhatia SS; Arya R; Narayanan G
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):170-5. PubMed ID: 26365547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress in cryoablation cancer therapy and nanoparticles mediated cryoablation.
    Kwak K; Yu B; Lewandowski RJ; Kim DH
    Theranostics; 2022; 12(5):2175-2204. PubMed ID: 35265206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparative Study of Ablation Boundary Sharpness After Percutaneous Radiofrequency, Cryo-, Microwave, and Irreversible Electroporation Ablation in Normal Swine Liver and Kidneys.
    Cornelis FH; Durack JC; Kimm SY; Wimmer T; Coleman JA; Solomon SB; Srimathveeravalli G
    Cardiovasc Intervent Radiol; 2017 Oct; 40(10):1600-1608. PubMed ID: 28516273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible electroporation in primary and metastatic hepatic malignancies: A review.
    Lyu T; Wang X; Su Z; Shangguan J; Sun C; Figini M; Wang J; Yaghmai V; Larson AC; Zhang Z
    Medicine (Baltimore); 2017 Apr; 96(17):e6386. PubMed ID: 28445252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).
    Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB
    Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CT-guided local ablative interventions].
    Bruners P
    Radiologie (Heidelb); 2023 Jul; 63(7):490-496. PubMed ID: 37306751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
    Distelmaier M; Barabasch A; Heil P; Kraemer NA; Isfort P; Keil S; Kuhl CK; Bruners P
    Radiology; 2017 Dec; 285(3):1023-1031. PubMed ID: 28799842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermal ablation of tumours: biological mechanisms and advances in therapy.
    Chu KF; Dupuy DE
    Nat Rev Cancer; 2014 Mar; 14(3):199-208. PubMed ID: 24561446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irreversible electroporation and electrochemotherapy in oncology: State of the art.
    Tasu JP; Tougeron D; Rols MP
    Diagn Interv Imaging; 2022 Nov; 103(11):499-509. PubMed ID: 36266192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "How we do it" - a practical approach to hepatic metastases ablation techniques.
    Sofocleous CT; Sideras P; Petre EN
    Tech Vasc Interv Radiol; 2013 Dec; 16(4):219-29. PubMed ID: 24238377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.